We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




New Gated Radiotherapy Technology Has Advanced Motion Management

By MedImaging International staff writers
Posted on 03 Jun 2010
Print article
New advanced motion management capabilities, including gated RapidArc, has been added to a radiotherapy platform for treating cancer with targeted radiotherapy (RT). A set of sophisticated new tools now enables clinicians to monitor and adjust for tumor motion during treatment, and to utilize respiratory gating during a RapidArc treatment.

"Extensive research and development into motion management systems has culminated in powerful new capabilities that will be standard on the new Trilogy accelerators and available as an upgrade on our large installed base of Trilogy and Clinac iX machines,” said Dow Wilson, president of Varian Medical Systems' (Palo Alto , CA, USA) oncology systems business. "Our Clinac iX and Trilogy accelerators together with our new TrueBeam platform can now offer clinics an unmatched combination of motion management, speed, and versatility."

Gated RapidArc radiotherapy makes it possible to monitor patient breathing and compensate for tumor motion while quickly delivering dose during a continuous rotation around the patient. This development enables the use of RapidArc to target lung tumors with greater precision by "gating” the beam--turning it on and off--in response to tumor motion. "With the new Gated RapidArc, it is possible to deliver highly targeted treatments to many types of tumors, including lung tumors that are moving, in less time than would otherwise be required,” said Mr. Wilson.

The new Trilogy system also incorporates an open interface that can be used with positioning devices such as the Calypso Medical (Seattle, WA, USA) system, allowing clinicians to monitor tumors in real time, gate the beam if the tumor moves outside of a pre-defined area, and make targeting adjustments when necessary. Varian and Calypso have been developing this capability under a strategic agreement to produce jointly products that integrate the two companies' technologies. "A recent peer-reviewed study [by H.M. Sandler, et al, and published in the May 2010 issue of the journal Urology] shows that gating the beam and repositioning the patient on the basis of signals from Calypso implanted transponders results in a significant reduction in patient reported side effects when delivering prostate cancer radiotherapy in the presence of tumor motion. Our new interface automates this process,” said Corey Zankowski, Varian's senior director of product management.

The motion management interface can also be used with surface imaging technologies from companies such as Vision RT to position the patient, to monitor continuously for any movement, and to gate the treatment beam either as a result of detected patient motion or according to the patient's breathing cycle.

The interface also opens the door for other third party companies to connect their devices to Varian accelerators for the purpose of monitoring motion. These capabilities are of particular importance during frameless radiosurgery and stereotactic body radiotherapy (SBRT) treatments. "Varian is committed to the continual development of an open architecture that makes it possible to interface with third-party technologies for the advancement of clinical care,” Mr. Zankowski added. "By working with other companies, we can offer clinics different methods for gathering and acting upon real-time information about tumor position during treatment.”

The Trilogy accelerator with gated RapidArc and advanced motion management is available to customers now. There are more than 1,600 Varian Clinac iX and Trilogy accelerators installed worldwide, eligible for upgrade with these new technologies.

"We anticipate that these enhancements will bring us another step closer to our mission of helping to save another 100,000 lives each year,” Mr. Wilson said. "Along with the new TrueBeam system that we introduced for oncology thought leaders interested in pioneering new approaches to cancer treatment, we now have the widest spectrum of advanced treatment solutions to meet the needs of our very diverse customers around the world.”

Related Links:
Varian Medical Systems
Calypso Medical


Ultrasound Table
Women’s Ultrasound EA Table
Ultra-Flat DR Detector
meX+1717SCC
New
Ultrasound-Guided Biopsy & Visualization Tools
Endoscopic Ultrasound (EUS) Guided Devices
X-ray Diagnostic System
FDX Visionary-A

Print article

Channels

Radiography

view channel
Image: AI can identify “mammographically-visible” types of interval cancers earlier by flagging them at the time of screening (Photo courtesy of ScreenPoint Medical)

AI Improves Early Detection of Interval Breast Cancers

Interval breast cancers, which occur between routine screenings, are easier to treat when detected earlier. Early detection can reduce the need for aggressive treatments and improve the chances of better outcomes.... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.